Document is current
Any future updates will be listed below
-
Authors
Jebessa, Zegeye H.
Shanmukha, Kumar D.
Dewenter, Matthias
Lehmann, Lorenz H.
Xu, Chang
Schreiter, Friederike
Siede, Dominik
Gong, Xue-Min
Worst, Barbara C.
Federico, Giuseppina
Sauer, Sven W.
Fischer, Tamas https://orcid.org/0000-0002-7996-4042
Wechselberger, Lisa
Müller, Oliver J. https://orcid.org/0000-0001-8223-2638
Sossalla, Samuel
Dieterich, Christoph
Most, Patrick
Gröne, Herrmann-Josef
Moro, Cedric
Oberer, Monika
Haemmerle, Guenter
Katus, Hugo A.
Tyedmers, Jens
Backs, Johannes https://orcid.org/0000-0002-2322-2699
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung
Bundesministerium für Bildung und Forschung (DZHK, DZHK)
Austrian Science Fund (F73 SFB)
Deutsche Forschungsgemeinschaft (BA 2258/9-1, BA 2258/2-1)
- License Information
-
More Information
Article History
Received: 28 August 2019
Accepted: 10 October 2019
First Online: 15 November 2019
Competing interests
: Z.H.J., L.H.L, O.J.M, H.A.K. and J.B. filed a patent on HDAC4-NT and ABHD5 gene therapy (US9914912B2). All other authors declare no competing interests.
